Multiple Sclerosis (MS) is a neuroinflammatory disorder, which is histopathologically
characterized by multifocal inflammatory demyelinating lesions affecting both the central …

Remyelination therapies, which are currently under development, have a great potential to
delay, prevent or even reverse disability in multiple sclerosis patients. Several models are …

Multiple sclerosis (MS) is a complex chronic disease with an unknown etiology. It is
considered an inflammatory demyelinating and neurodegenerative disorder of the central …

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
characterized by demyelination and axonal degeneration. MS patients typically present with …

Increasing evidence foresees the secretome of neural stem cells (NSCs) to confer
superimposable beneficial properties as exogenous NSC transplants in experimental …

Oligodendrocytes are a type of glial cells that produce a lipid‐rich membrane called myelin.
Myelin assembles into a sheath and lines neuronal axons in the brain and spinal cord to …

Spinal cord injury (SCI) leads to irreversible functional impairment caused by neuronal loss
and the disruption of neuronal connections across the injury site. While several experimental …

Spinocerebellar ataxias are heritable neurodegenerative diseases caused by a cytosine-
adenine-guanine expansion, which encodes a long glutamine tract (polyglutamine) in the …

Traumatic brain injury (TBI) causes chronic symptoms and increased risk of
neurodegeneration. Axons in white matter tracts, such as the corpus callosum (CC), are …

Multiple sclerosis is an autoimmune disease characterised by demyelination in the central
nervous system. The cuprizone-induced demyelination model is often used in mice to test …